Clinical Trials Directory

Trials / Completed

CompletedNCT01302262

Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in Humans

Does the Insula Control Smoking-induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans. Part I: Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in Humans.

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate effects of smoking on the dopaminergic system by using PET tomography with new radioligand, \[11C\]-(+)-PHNO. Our primary hypothesis is that smoking a cigarette will produce dopamine release and this release can be measured using PET imaging and the \[11C\]-(+)-PHNO radiotracer. The secondary hypothesis is that this smoking induced dopamine release will be correlated with subjective craving and anxiety ratings.

Detailed description

This will be a within-subjects study in healthy male and female smokers. There will be one within factor condition: Smoking and Non Smoking. Therefore, there will be a repeated measure of PET scans using \[11C\]-(+)-PHNO under two different conditions. Ten subjects (n=5 male and n=5 female) included in the study will come on two different days and will have a Smoking or Non smoking session performed just before the PET study. Subjective assessments will be conducted at each experimental condition.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2013-02-01
Completion
2013-03-01
First posted
2011-02-24
Last updated
2013-03-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01302262. Inclusion in this directory is not an endorsement.